In conclusion, our meta‐regression analysis reveals key determinants affecting VEGF‐A expression in patients with ALL, underscoring the importance of accounting for age, geographic region, and gender in both research settings and clinical management. The gene discussed is VEGFA; the disease is acute lymphoblastic leukemia.